/Companies

Xerient

2 known investors

Find your way into Xerient

Sign up to see every warm intro you have to Xerient

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Xerient team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Xerient is a biopharmaceutical company developing oncology treatments, with expertise in clinical trial design, radiation oncology, and translational cancer research for gastrointestinal malignancies.

Founders & leadership

GYGuy Yachin
Guy YachinCo-Founder & CEO
DM
Dr. Michael ShteinCo-Founder & CSO
PCProf. Cullen Taniguchi
Prof. Cullen TaniguchiCo-Founder

Investors · 2

Frequently asked questions

What does Xerient do?
Xerient is a biopharmaceutical company developing oncology treatments, with expertise in clinical trial design, radiation oncology, and translational cancer research for gastrointestinal malignancies.
Who founded Xerient?
Xerient was founded by Guy Yachin, Dr. Michael Shtein, Prof. Cullen Taniguchi.
Who are Xerient's investors?
Xerient's investors include Peregrine Ventures, SIBF (Southern Israel Bridging Fund) VC.